Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
Continue using paclitaxel-eluting PAD devices
Manage episode 236996288 series 2355282
This week's top stories in cardiology:
- FDA Panel: Continue using paclitaxel-eluting PAD Devices, with caveats. Although the benefits of the devices were clear, the panel felt there should be a label change to warn of the late mortality signal seen in a key meta-analysis.
Many cardiac cath, electrophysiology lab directors receive big industry payments
These payments were substantially higher than those made to local interventional cardiologists and electrophysiologist.
Two trials support shorter DAPT
DAPT with a twist: Continuing the P2Y12 inhibitor instead of aspirin.
Do black patients with type 2 diabetes gain cardiac benefit from the SGLT2 and GLP-1 drugs?
New findings suggest there is no effect on cardiovascular outcomes, although the analysis has limitations
87 tập
Manage episode 236996288 series 2355282
This week's top stories in cardiology:
- FDA Panel: Continue using paclitaxel-eluting PAD Devices, with caveats. Although the benefits of the devices were clear, the panel felt there should be a label change to warn of the late mortality signal seen in a key meta-analysis.
Many cardiac cath, electrophysiology lab directors receive big industry payments
These payments were substantially higher than those made to local interventional cardiologists and electrophysiologist.
Two trials support shorter DAPT
DAPT with a twist: Continuing the P2Y12 inhibitor instead of aspirin.
Do black patients with type 2 diabetes gain cardiac benefit from the SGLT2 and GLP-1 drugs?
New findings suggest there is no effect on cardiovascular outcomes, although the analysis has limitations
87 tập
Tất cả các tập
×Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.